Publié le 27 août 2024 – Mis à jour le 25 septembre 2024

Qualified researchers presented keynote lectures and Belgian PhD or postdoc students presented short communications.

Here is the complete progarm of that successful day:

9h-9h15: coffee- welcome

Section 1: antimycobacterial drug resistances and assessments

9h15-10h: Prof. Leen Rigouts (Institute of Tropical Medicine, Antwerp, Belgium) on “Genetic variants across phylogenetic lineages of Mycobacterium tuberculosis complex may cause resistance in drug-naïve populations”.

Section 2: New antimycobacterial and antimicrobial compounds and strategies

10h00-10h45: Prof. Jayanta Haldar (JNCASR, Bangalore, India)  on « Vancomycin analogues in the pipeline of antimicrobial drug development”.

11h00-11h20: Dr. Qianqian Wei (3BIO-BioMatter, U.L.B.) on “A novel bioactive polycaprolactone material with antibacterial property for biomedical application”.

11h30-11h50: Prof. Mohit Kumar (Hindu College, University of Delhi, India) on “Removal of penicillin by Serratia”.

12h-13h: lunch at the restaurant “La Maison des Anciens”

13h00- 13h45: Prof. Alain Baulard (Institut Pasteur de Lille, France) on « Rewiring M. tuberculosis to reverse antibiotic resistance: Alpibectir from bench to bedside”

14h- 14h20: Dr. Gilles Henon (UNamur) on “Identification and development of new disruptors of protein-protein interactions as new inhibitors of M. tuberculosis phosphoserine phosphatase”

14h30-15h15 : Prof. Gilles Berger (Fac. Pharmacy, U.L.B.) on « Exploring transition metal complexes for human diseases »

15h15-16h : Prof. Véronique Fontaine (Fac. Pharmacy, U.L.B.) on “Why to target GroEL1 and PDIM biosynthesis to fight M. tuberculosis”

This event is subsidized by Belspo (Project TBNewvan of Prof. Véronique Fontaine, Belgium and Prof. Jayanta Haldar, India).
Date(s)

16 September 2024, 9 am-16 pm

Lieu(x)

Location: Brussels, Université Libre de Bruxelles (ULB), Campus Plaine, building NO, 5th floor, room Solvay